Post-stroke lateropulsion terminology: pushing for agreement amongst experts.

Lateropulsion Pusher behaviour Pusher syndrome Stroke rehabilitation

Journal

Annals of physical and rehabilitation medicine
ISSN: 1877-0665
Titre abrégé: Ann Phys Rehabil Med
Pays: Netherlands
ID NLM: 101502773

Informations de publication

Date de publication:
Nov 2022
Historique:
received: 02 03 2022
revised: 27 04 2022
accepted: 20 05 2022
pubmed: 7 6 2022
medline: 23 11 2022
entrez: 6 6 2022
Statut: ppublish

Résumé

Post-stroke lateropulsion is prevalent. The global inconsistency in terminology used to describe the condition presents obstacles in accurately comparing research results, reaching consensus on use of measurement tools, agreeing upon a consistent approach to rehabilitation, and translating research to clinical practice. Commencing in 2021, 20 international experts undertook a Delphi Process that aimed to compile clinical practice recommendations for the rehabilitation of lateropulsion. As a part of the process, the panel agreed to aim to reach consensus regarding terminology used to describe the condition. Improved understanding of the condition could lead to improved management, which will enhance patient outcomes after stroke and increase efficiency of healthcare resource utilisation. While consensus was not reached, the panel achieved some agreement that 'lateropulsion' is the preferred term to describe the phenomenon of 'active pushing of the body across the midline toward the more affected side, and / or actively resisting weight shift toward the less affected side'. This group recommends that 'lateropulsion' is used in future research and in clinical practice.

Identifiants

pubmed: 35667626
pii: S1877-0657(22)00057-4
doi: 10.1016/j.rehab.2022.101684
pii:
doi:

Types de publication

Letter

Langues

eng

Sous-ensembles de citation

IM

Pagination

101684

Informations de copyright

Copyright © 2022 Elsevier Masson SAS. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Jessica Nolan (J)

School of Medical and Health Sciences, Edith Cowan University, Osborne Park Hospital, Joondalup, Stirling, Australia. Electronic address: jess.nolan@health.wa.gov.au.

Angela Jacques (A)

Institute for Health Research, The University of Notre Dame Australia, Department of Research, Sir Charles Gairdner Hospital, Fremantle, Nedlands, Australia.

Erin Godecke (E)

School of Medical and Health Sciences, Sir Charles Gairdner Hospital, Centre of Research Excellence in Aphasia Recovery and Rehabilitation, La Trobe University, Edith Cowan University, Joondalup, Melbourne, Nedlands, Vic, Australia.

Hiroaki Abe (H)

Fukushima Medical University, Fukushima, Japan.

Suzanne Babyar (S)

Hunter College, Burke Rehabilitation Hospital, New York, White Plains, NY, United States.

Jeannine Bergmann (J)

Schoen Clinic, Ludwig-Maximilians University of Munich, German Center for Vertigo and Balance Disorders (DSGZ), Bad Aibling, Munich, Germany.

Melissa Birnbaum (M)

St Vincent's Hospital, Melbourne, Vic, Australia.

Shenhao Dai (S)

UMR CNRS 5105 Neuropsychology and NeuroCognition, Univ. Grenoble Alpes, CHU Grenoble Alpes, Dept of NeuroRehabilitation South Hospital, Cs 10217 - 38043 cedex 9 Grenoble, France.

Cynthia Danells (C)

KITE-Toronto Rehabilitation Institute, University Health Network, University of Toronto, Toronto, ON, Canada.

Taiza Gs Edwards (TG)

Department of Neurosciences and Behavioral Sciences, Ribeirao Preto Medical School, University of Sao Paulo, Sao Paulo, Brazil.

Marialuisa Gandolfi (M)

Department of Neurosciences, Biomedicine and Movement Sciences, Neurorehabilitation Unit, AOUI Verona, Neuromotor and Cognitive Rehabilitation Research Center (CRRNC), University of Verona, Verona, Italy.

Klaus Jahn (K)

Schoen Clinic, German Center for Vertigo and Balance Disorders (DSGZ), Ludwig-Maximilians University of Munich, Bad Aibling, Munich Germany.

Ryan Koter (R)

Sherherd Center, Atlanta, GA, United States.

Avril Mansfield (A)

KITE-Toronto Rehabilitation Institute, University Health Network, University of Toronto, Sunnybrook Research Institute, Toronto, ON, Canada.

Junji Nakamura (J)

Nishiyamato Rehabilitation Hospital, Graduate School of Health Sciences, Kio University, Nara, Japan.

Vicky Pardo (V)

Wayne State University, Detroit, MI, United States.

Dominic Perennou (D)

UMR CNRS 5105 Neuropsychology and NeuroCognition, Univ. Grenoble Alpes, CHU Grenoble Alpes, Dept of NeuroRehabilitation South Hospital, Cs 10217 - 38043 cedex 9 Grenoble, France.

Celine Piscicelli (C)

UMR CNRS 5105 Neuropsychology and NeuroCognition, Univ. Grenoble Alpes, CHU Grenoble Alpes, Dept of NeuroRehabilitation South Hospital, Cs 10217 - 38043 cedex 9 Grenoble, France.

David Punt (D)

University of Birmingham, Birmingham, UK.

Devra Romick-Sheldon (D)

Schwab Rehabilitation Hospital, Chicago, IL, United States.

Wim Saeys (W)

University of Antwerp, Rehabilitation Sciences and Physiotherapy, Wilrijk, Belgium.

Nicola Smania (N)

Neurorehabilitation Unit, AOUI Verona, Neuromotor and Cognitive Rehabilitation Research Center (CRRNC), Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.

Nathalie Vaes (N)

Rehabilitation Hospital RevArte, Antwerp, Belgium; Rehabilitation Research Group, Department of Physiotherapy, Human Physiology and Anatomy, Vrije Universiteit Brussel, Brussels, Belgium.

Abigail L Whitt (AL)

Inova Fairfax Hospital Health System, Fairfax, VA, United States.

Barbara Singer (B)

School of Medical and Health Sciences, Training Centre in Subacute Care, South Metropolitan Health Service, Edith Cowan University, Fremantle Hospital, Fremantle, Joondalup, WA, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH